首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷核子醫學

市場調查報告書

商品編碼

1657137

2025-2029 年全球放射性藥物市場

Global Radiopharmaceuticals Market 2025-2029

出版日期: 2025年02月08日 | 出版商:

TechNavio | 英文 214 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

預計放射性藥物市場規模將在 2024 年至 2029 年間達到 70.205 億美元，預測期內複合年成長率為 12.3%。

本報告對放射性藥物市場進行了全面的分析，包括市場規模、預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了當前市場情景、最新趨勢和促進因素以及整體市場環境的最新分析。推動市場發展的因素包括神經系統疾病發生率上升、癌症患者數量增加、腫瘤市場投資增加、放射性藥物副作用的減少。

市場覆蓋
基準年	2025
年底	2029
預測期	2025-2029
成長動力	加速度
與前一年同期比較[2025]	10.7％
複合年成長率	12.3％
增量金額	70.205億美元

這項研究採用了一手資料和二手資料的客觀組合，包括來自業界主要參與者的意見。該報告包括全面的市場規模資料（按區域分析和供應商格局細分）以及對主要企業的分析。報告包括資料和預測資料。

研究發現，基於迴旋加速器的放射性藥物生產是未來幾年推動放射性藥物市場成長的主要原因之一。此外，預計新型放射性藥物的發現和開發以及新興經濟體醫療基礎設施的改善將帶來巨大的市場需求。

地理細分
比較：按地區
北美：2024 年至 2029 年的市場規模與預測
歐洲：2024 年至 2029 年市場規模及預測
亞洲：2024 年至 2029 年市場規模及預測
其他：2024-2029 年市場規模及預測
美國：2024 年至 2029 年市場規模及預測
德國：2024-2029 年市場規模及預測
英國：2024-2029 年市場規模與預測
加拿大：市場規模與預測 2024-2029
中國：2024-2029 年市場規模及預測
日本：2024 年至 2029 年市場規模及預測
法國：2024-2029 年市場規模及預測
巴西：2024 年至 2029 年市場規模及預測
印度：2024-2029 年市場規模及預測
阿拉伯聯合大公國：市場規模與預測 2024-2029
區域市場機會

第13章促進因素、挑戰、機會與限制因素

市場促進因素
市場問題
促進因素和挑戰的影響
市場機會與限制

第14章競爭格局

概述
競爭格局
令人困惑的情況
產業風險

第15章競爭分析

公司簡介
企業排名指數
公司市場定位
Bayer AG
Bracco Spa
Cardinal Health Inc.
Curium Pharma
Eckert and Ziegler AG
GE Healthcare Technologies Inc.
IBA Radiopharma Solutions
Jubilant Draximage Radiopharmacies Inc.
Lantheus
NorthStar Medical Radioisotopes LLC
Novartis AG
NTP Radioisotopes SOC Ltd.
PharmaLogic Holdings Corp.
Siemens AG
Sotera Health Co.

第16章附錄

簡介目錄圖表

Product Code: IRTNTR43963

The radiopharmaceuticals market is forecasted to grow by USD 7020.5 million during 2024-2029, accelerating at a CAGR of 12.3% during the forecast period. The report on the radiopharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of neurological disorders, growing cancer cases and rising investment in oncology market, and minimal side effects of radiopharmaceuticals.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	10.7%
CAGR	12.3%
Incremental Value	$7020.5 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's radiopharmaceuticals market is segmented as below:

By Source

Cyclotrons
Nuclear reactors

By End-user

Diagnostics
Therapeutics

By Application

Oncology
Cardiology
Neurology

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the production of cyclotron-based radiopharmaceuticals as one of the prime reasons driving the radiopharmaceuticals market growth during the next few years. Also, discovery and development of new radiopharmaceuticals and improvement in healthcare infrastructure in emerging economies will lead to sizable demand in the market.

The report on the radiopharmaceuticals market covers the following areas:

Radiopharmaceuticals Market sizing
Radiopharmaceuticals Market forecast
Radiopharmaceuticals Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radiopharmaceuticals market vendors that include Bayer AG, Bracco Spa, Cardinal Health Inc., Curium Pharma, Eckert and Ziegler AG, GE Healthcare Technologies Inc., IBA Radiopharma Solutions, Jubilant Draximage Radiopharmacies Inc., Lantheus, Mallinckrodt PLC, NorthStar Medical Radioisotopes LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings Corp., Positron Corp., Radiomedix Inc., Siemens AG, Sinotau Pharmaceuticals, Sotera Health Co., and Telix Pharmaceuticals Ltd.. Also, the radiopharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Source
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Radiopharmaceuticals Market 2019 - 2023
- Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2019 - 2023 ($ million)
5.2 Source segment analysis 2019 - 2023
- Historic Market Size - Source Segment 2019 - 2023 ($ million)
5.3 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.4 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 AI Impact on Global Radiopharmaceuticals Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Source

8.1 Market segments
- Chart on Source - Market share 2024-2029 (%)
- Data Table on Source - Market share 2024-2029 (%)
8.2 Comparison by Source
- Chart on Comparison by Source
- Data Table on Comparison by Source
8.3 Cyclotrons - Market size and forecast 2024-2029
- Chart on Cyclotrons - Market size and forecast 2024-2029 ($ million)
- Data Table on Cyclotrons - Market size and forecast 2024-2029 ($ million)
- Chart on Cyclotrons - Year-over-year growth 2024-2029 (%)
- Data Table on Cyclotrons - Year-over-year growth 2024-2029 (%)
8.4 Nuclear reactors - Market size and forecast 2024-2029
- Chart on Nuclear reactors - Market size and forecast 2024-2029 ($ million)
- Data Table on Nuclear reactors - Market size and forecast 2024-2029 ($ million)
- Chart on Nuclear reactors - Year-over-year growth 2024-2029 (%)
- Data Table on Nuclear reactors - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Source
- Market opportunity by Source ($ million)
- Data Table on Market opportunity by Source ($ million)

9 Market Segmentation by End-user

9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
9.3 Diagnostics - Market size and forecast 2024-2029
- Chart on Diagnostics - Market size and forecast 2024-2029 ($ million)
- Data Table on Diagnostics - Market size and forecast 2024-2029 ($ million)
- Chart on Diagnostics - Year-over-year growth 2024-2029 (%)
- Data Table on Diagnostics - Year-over-year growth 2024-2029 (%)
9.4 Therapeutics - Market size and forecast 2024-2029
- Chart on Therapeutics - Market size and forecast 2024-2029 ($ million)
- Data Table on Therapeutics - Market size and forecast 2024-2029 ($ million)
- Chart on Therapeutics - Year-over-year growth 2024-2029 (%)
- Data Table on Therapeutics - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

10 Market Segmentation by Application

10.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
10.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
10.3 Oncology - Market size and forecast 2024-2029
- Chart on Oncology - Market size and forecast 2024-2029 ($ million)
- Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
- Chart on Oncology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology - Year-over-year growth 2024-2029 (%)
10.4 Cardiology - Market size and forecast 2024-2029
- Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
- Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
- Chart on Cardiology - Year-over-year growth 2024-2029 (%)
- Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
10.5 Neurology - Market size and forecast 2024-2029
- Chart on Neurology - Market size and forecast 2024-2029 ($ million)
- Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
- Chart on Neurology - Year-over-year growth 2024-2029 (%)
- Data Table on Neurology - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.12 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ million)
- Data Table on UAE - Market size and forecast 2024-2029 ($ million)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
15.5 Bracco Spa
- Bracco Spa - Overview
- Bracco Spa - Product / Service
- Bracco Spa - Key offerings
- SWOT
15.6 Cardinal Health Inc.
- Cardinal Health Inc. - Overview
- Cardinal Health Inc. - Business segments
- Cardinal Health Inc. - Key news
- Cardinal Health Inc. - Key offerings
- Cardinal Health Inc. - Segment focus
- SWOT
15.7 Curium Pharma
- Curium Pharma - Overview
- Curium Pharma - Product / Service
- Curium Pharma - Key offerings
- SWOT
15.8 Eckert and Ziegler AG
- Eckert and Ziegler AG - Overview
- Eckert and Ziegler AG - Business segments
- Eckert and Ziegler AG - Key news
- Eckert and Ziegler AG - Key offerings
- Eckert and Ziegler AG - Segment focus
- SWOT
15.9 GE Healthcare Technologies Inc.
- GE Healthcare Technologies Inc. - Overview
- GE Healthcare Technologies Inc. - Business segments
- GE Healthcare Technologies Inc. - Key news
- GE Healthcare Technologies Inc. - Key offerings
- GE Healthcare Technologies Inc. - Segment focus
- SWOT
15.10 IBA Radiopharma Solutions
- IBA Radiopharma Solutions - Overview
- IBA Radiopharma Solutions - Business segments
- IBA Radiopharma Solutions - Key news
- IBA Radiopharma Solutions - Key offerings
- IBA Radiopharma Solutions - Segment focus
- SWOT
15.11 Jubilant Draximage Radiopharmacies Inc.
- Jubilant Draximage Radiopharmacies Inc. - Overview
- Jubilant Draximage Radiopharmacies Inc. - Product / Service
- Jubilant Draximage Radiopharmacies Inc. - Key offerings
- SWOT
15.12 Lantheus
- Lantheus - Overview
- Lantheus - Business segments
- Lantheus - Key offerings
- Lantheus - Segment focus
- SWOT
15.13 NorthStar Medical Radioisotopes LLC
- NorthStar Medical Radioisotopes LLC - Overview
- NorthStar Medical Radioisotopes LLC - Product / Service
- NorthStar Medical Radioisotopes LLC - Key offerings
- SWOT
15.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.15 NTP Radioisotopes SOC Ltd.
- NTP Radioisotopes SOC Ltd. - Overview
- NTP Radioisotopes SOC Ltd. - Product / Service
- NTP Radioisotopes SOC Ltd. - Key offerings
- SWOT
15.16 PharmaLogic Holdings Corp.
- PharmaLogic Holdings Corp. - Overview
- PharmaLogic Holdings Corp. - Product / Service
- PharmaLogic Holdings Corp. - Key offerings
- SWOT
15.17 Siemens AG
- Siemens AG - Overview
- Siemens AG - Business segments
- Siemens AG - Key news
- Siemens AG - Key offerings
- Siemens AG - Segment focus
- SWOT
15.18 Sotera Health Co.
- Sotera Health Co. - Overview
- Sotera Health Co. - Business segments
- Sotera Health Co. - Key news
- Sotera Health Co. - Key offerings
- Sotera Health Co. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

簡介目錄圖表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Source
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Market Segmentation by Application
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Source Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Source - Market share 2024-2029 (%)
Exhibits39: Data Table on Source - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Source
Exhibits41: Data Table on Comparison by Source
Exhibits42: Chart on Cyclotrons - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on Cyclotrons - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on Cyclotrons - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Cyclotrons - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Nuclear reactors - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Nuclear reactors - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Nuclear reactors - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Nuclear reactors - Year-over-year growth 2024-2029 (%)
Exhibits50: Market opportunity by Source ($ million)
Exhibits51: Data Table on Market opportunity by Source ($ million)
Exhibits52: Chart on End-user - Market share 2024-2029 (%)
Exhibits53: Data Table on End-user - Market share 2024-2029 (%)
Exhibits54: Chart on Comparison by End-user
Exhibits55: Data Table on Comparison by End-user
Exhibits56: Chart on Diagnostics - Market size and forecast 2024-2029 ($ million)
Exhibits57: Data Table on Diagnostics - Market size and forecast 2024-2029 ($ million)
Exhibits58: Chart on Diagnostics - Year-over-year growth 2024-2029 (%)
Exhibits59: Data Table on Diagnostics - Year-over-year growth 2024-2029 (%)
Exhibits60: Chart on Therapeutics - Market size and forecast 2024-2029 ($ million)
Exhibits61: Data Table on Therapeutics - Market size and forecast 2024-2029 ($ million)
Exhibits62: Chart on Therapeutics - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on Therapeutics - Year-over-year growth 2024-2029 (%)
Exhibits64: Market opportunity by End-user ($ million)
Exhibits65: Data Table on Market opportunity by End-user ($ million)
Exhibits66: Chart on Application - Market share 2024-2029 (%)
Exhibits67: Data Table on Application - Market share 2024-2029 (%)
Exhibits68: Chart on Comparison by Application
Exhibits69: Data Table on Comparison by Application
Exhibits70: Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits71: Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits72: Chart on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits73: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits74: Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
Exhibits75: Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
Exhibits76: Chart on Cardiology - Year-over-year growth 2024-2029 (%)
Exhibits77: Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
Exhibits78: Chart on Neurology - Market size and forecast 2024-2029 ($ million)
Exhibits79: Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
Exhibits80: Chart on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits81: Data Table on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits82: Market opportunity by Application ($ million)
Exhibits83: Data Table on Market opportunity by Application ($ million)
Exhibits84: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits85: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits86: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits87: Chart on Geographic comparison
Exhibits88: Data Table on Geographic comparison
Exhibits89: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits90: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits91: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits92: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits93: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits94: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits95: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on UAE - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on UAE - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on UAE - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on UAE - Year-over-year growth 2024-2029 (%)
Exhibits145: Market opportunity By Geographical Landscape ($ million)
Exhibits146: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits147: Impact of drivers and challenges in 2024 and 2029
Exhibits148: Overview on criticality of inputs and factors of differentiation
Exhibits149: Overview on factors of disruption
Exhibits150: Impact of key risks on business
Exhibits151: Companies covered
Exhibits152: Company ranking index
Exhibits153: Matrix on companies position and classification
Exhibits154: Bayer AG - Overview
Exhibits155: Bayer AG - Business segments
Exhibits156: Bayer AG - Key news
Exhibits157: Bayer AG - Key offerings
Exhibits158: Bayer AG - Segment focus
Exhibits159: SWOT
Exhibits160: Bracco Spa - Overview
Exhibits161: Bracco Spa - Product / Service
Exhibits162: Bracco Spa - Key offerings
Exhibits163: SWOT
Exhibits164: Cardinal Health Inc. - Overview
Exhibits165: Cardinal Health Inc. - Business segments
Exhibits166: Cardinal Health Inc. - Key news
Exhibits167: Cardinal Health Inc. - Key offerings
Exhibits168: Cardinal Health Inc. - Segment focus
Exhibits169: SWOT
Exhibits170: Curium Pharma - Overview
Exhibits171: Curium Pharma - Product / Service
Exhibits172: Curium Pharma - Key offerings
Exhibits173: SWOT
Exhibits174: Eckert and Ziegler AG - Overview
Exhibits175: Eckert and Ziegler AG - Business segments
Exhibits176: Eckert and Ziegler AG - Key news
Exhibits177: Eckert and Ziegler AG - Key offerings
Exhibits178: Eckert and Ziegler AG - Segment focus
Exhibits179: SWOT
Exhibits180: GE Healthcare Technologies Inc. - Overview
Exhibits181: GE Healthcare Technologies Inc. - Business segments
Exhibits182: GE Healthcare Technologies Inc. - Key news
Exhibits183: GE Healthcare Technologies Inc. - Key offerings
Exhibits184: GE Healthcare Technologies Inc. - Segment focus
Exhibits185: SWOT
Exhibits186: IBA Radiopharma Solutions - Overview
Exhibits187: IBA Radiopharma Solutions - Business segments
Exhibits188: IBA Radiopharma Solutions - Key news
Exhibits189: IBA Radiopharma Solutions - Key offerings
Exhibits190: IBA Radiopharma Solutions - Segment focus
Exhibits191: SWOT
Exhibits192: Jubilant Draximage Radiopharmacies Inc. - Overview
Exhibits193: Jubilant Draximage Radiopharmacies Inc. - Product / Service
Exhibits194: Jubilant Draximage Radiopharmacies Inc. - Key offerings
Exhibits195: SWOT
Exhibits196: Lantheus - Overview
Exhibits197: Lantheus - Business segments
Exhibits198: Lantheus - Key offerings
Exhibits199: Lantheus - Segment focus
Exhibits200: SWOT
Exhibits201: NorthStar Medical Radioisotopes LLC - Overview
Exhibits202: NorthStar Medical Radioisotopes LLC - Product / Service
Exhibits203: NorthStar Medical Radioisotopes LLC - Key offerings
Exhibits204: SWOT
Exhibits205: Novartis AG - Overview
Exhibits206: Novartis AG - Business segments
Exhibits207: Novartis AG - Key news
Exhibits208: Novartis AG - Key offerings
Exhibits209: Novartis AG - Segment focus
Exhibits210: SWOT
Exhibits211: NTP Radioisotopes SOC Ltd. - Overview
Exhibits212: NTP Radioisotopes SOC Ltd. - Product / Service
Exhibits213: NTP Radioisotopes SOC Ltd. - Key offerings
Exhibits214: SWOT
Exhibits215: PharmaLogic Holdings Corp. - Overview
Exhibits216: PharmaLogic Holdings Corp. - Product / Service
Exhibits217: PharmaLogic Holdings Corp. - Key offerings
Exhibits218: SWOT
Exhibits219: Siemens AG - Overview
Exhibits220: Siemens AG - Business segments
Exhibits221: Siemens AG - Key news
Exhibits222: Siemens AG - Key offerings
Exhibits223: Siemens AG - Segment focus
Exhibits224: SWOT
Exhibits225: Sotera Health Co. - Overview
Exhibits226: Sotera Health Co. - Business segments
Exhibits227: Sotera Health Co. - Key news
Exhibits228: Sotera Health Co. - Key offerings
Exhibits229: Sotera Health Co. - Segment focus
Exhibits230: SWOT
Exhibits231: Inclusions checklist
Exhibits232: Exclusions checklist
Exhibits233: Currency conversion rates for US$
Exhibits234: Research methodology
Exhibits235: Information sources
Exhibits236: Data validation
Exhibits237: Validation techniques employed for market sizing
Exhibits238: Data synthesis
Exhibits239: 360 degree market analysis
Exhibits240: List of abbreviations